Fact CheckerSign in

NCT05132517Recruiting

Magnesium and Cognition After Stroke

Relationship Between Magnesium Concentration in Blood and Kognitive Functions After Stroke

Source: ClinicalTrials.gov · Last updated 20 Apr 2026

Brief summary (registry, in English)

Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients. Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
11 Oct 2021
Start date
26 Oct 2022
Primary completion date
31 Dec 2026
Lead sponsor
BDH-Klinik Hessisch Oldendorf
Diseases
Stroke
NCT number
NCT05132517

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 26 Oct 2022 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • pre-existing mental disorder (depression) or present/prior long-term treatment (\> 6 months) with psychotropic drugs

Other illness

  • pre-existing dementia or cognitive impairment before stroke onset
  • pre-existing malign tumor disease

Other

  • participation in another clinical trial within the past 30 days
  • pregnancy or breastfeeding

Who the study is looking for

  • ischemic/hemmorhagic stroke
  • written consent form

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute for Neurorehabilitation Research, BDH-Clinic Hessich Oldendorf
Coordinator of this site? Confirm its status
Hessisch OldendorfGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.